Medicine
Sodium Iodide I 131 Diagnostic 100 mCi capsule
Sodium Iodide I 131 Diagnostic 100 mCi capsule is a prescription medicine containing Sodium iodide i-131 for oral use, marketed by Jubilant Radiopharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store Sodium Iodide I 131 Capsules Diagnostic between 15 °C and 30 °C (59 °F…
Key facts
- Active ingredient (INN)
- Sodium iodide i-131
- Brand
- Sodium Iodide I 131 Diagnostic
- Strength
- 100 mCi
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 5 capsules
- Marketing authorisation holder
- Jubilant Radiopharma
- Manufacturer
- Jubilant RadiopharmaIndia
- Origin register
- US FDA, United States
- Storage
- Store Sodium Iodide I 131 Capsules Diagnostic between 15 °C and 30 °C (59 °F and 86 °F). Store and dispose of Sodium Iodide I 131 Capsules Diagnostic in compliance with the appropriate regulations of the government agency authorized to license the use of this radionuclide.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V10XA01 Sodium iodide i-131
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 May 2006
- Identifiers
- DailyMed set ID 46b8d7ba-432d-d610-84f2-550bf9d0bae3NDC 65174-461Application NDA021305
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 capsule in 1 vial | 65174-461-05 | Jubilant RadiopharmaIndia | 1 May 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 May 1957 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sodium iodide i-131
Clinical summary
Sodium iodide i-131 is a radioactive therapeutic agent indicated for the treatment of hyperthyroidism and selected cases of thyroid carcinoma. It is available as capsules and oral solution. MedsAcross supplies Sodium iodide i-131 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium iodide i-131For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- HICON prescribing information (Jubilant Radiopharma) · U.S. National Library of Medicine, DailyMed
Need Sodium Iodide I 131 Diagnostic 100 mCi capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.